DE60336549D1 - Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure - Google Patents

Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure

Info

Publication number
DE60336549D1
DE60336549D1 DE60336549T DE60336549T DE60336549D1 DE 60336549 D1 DE60336549 D1 DE 60336549D1 DE 60336549 T DE60336549 T DE 60336549T DE 60336549 T DE60336549 T DE 60336549T DE 60336549 D1 DE60336549 D1 DE 60336549D1
Authority
DE
Germany
Prior art keywords
mussaenosic
hepatoprotector
hydroxybenzoyl
activity
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60336549T
Other languages
English (en)
Inventor
Anil Prabhakar
Bishan Datt Gupta
Krishan Avtar Suri
I Naresh Kumar Sat
Swadesh Malhotra
Kuldip Kumar Gupta
Vijay Kumar Sharma
Rakesh Kamal Johri
Bupinder S Jaggi
Bal K Chandan
Shankar Lal
Kasturi Lal Bedi
Om Parkash Suri
Gulam Nabi Qazi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Application granted granted Critical
Publication of DE60336549D1 publication Critical patent/DE60336549D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/85—Verbenaceae (Verbena family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Addiction (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
DE60336549T 2002-05-10 2003-05-09 Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure Expired - Lifetime DE60336549D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37930302P 2002-05-10 2002-05-10
PCT/IB2003/001808 WO2003094946A1 (en) 2002-05-10 2003-05-09 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid

Publications (1)

Publication Number Publication Date
DE60336549D1 true DE60336549D1 (de) 2011-05-12

Family

ID=29420507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60336549T Expired - Lifetime DE60336549D1 (de) 2002-05-10 2003-05-09 Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure

Country Status (8)

Country Link
US (1) US7259148B2 (de)
EP (1) EP1503773B9 (de)
JP (1) JP4594080B2 (de)
CN (1) CN100391465C (de)
AU (1) AU2003224361B2 (de)
DE (1) DE60336549D1 (de)
WO (1) WO2003094946A1 (de)
ZA (1) ZA200409048B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338674B2 (en) * 2004-12-23 2008-03-04 Council Of Scientific And Industrial Research Anti-arthritic herbal composition and method thereof
CN102391332B (zh) * 2011-09-20 2014-09-24 华中科技大学 一种保肝化合物及其制备方法和用途
BR102017003318A2 (pt) * 2017-02-17 2018-10-30 Aché Laboratórios Farmacêuticos S.A. compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943282B1 (en) * 1983-09-26 2005-09-13 Mycogen Plant Science, Inc. Insect resistant plants
JPS6037999A (ja) * 1983-08-09 1985-02-27 Osaka Chem Lab 肝障害有効薬物の簡易試験法
US4889918A (en) * 1983-12-21 1989-12-26 Boehringer Mannheim Gmbh Protein tokin from bacillus thiringiensis which is toxic to coleoptera
US5338544A (en) * 1987-04-16 1994-08-16 Ecogen Inc. CryIIB protein, insecticidal compositions and methods of use thereof
US5187091A (en) * 1990-03-20 1993-02-16 Ecogen Inc. Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects
EP0505572A4 (en) * 1990-10-09 1993-03-10 Tsumura & Co. Iridoide derivative and its use as medicine
ES2124738T3 (es) * 1991-08-02 1999-02-16 Mycogen Corp Nuevo microorganismo e insecticida.
US5962765A (en) * 1991-08-08 1999-10-05 Boyce Thompson Institute For Plant Research, Inc. Molecular cloning of a complimentary DNA sequence encoding a cuticle degrading protease produced by entomopathogenic fungi
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US5712248A (en) * 1992-02-27 1998-01-27 Sandoz Ltd. Method of controlling insect with novel insecticidal protein
KR100218052B1 (ko) * 1992-07-15 1999-09-01 이병언 B형 간염 바이러스의 복제를 억제하는 약학적 제제
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
WO1995017515A1 (en) * 1993-12-23 1995-06-29 University Technologies International Inc. Methods of expressing proteins in insect cells and methods of killing insects
US5759538A (en) * 1995-03-31 1998-06-02 Monsanto Company Bacillus thuringiensis apr and npr genes, apr and npr B.t. strains, and method of use
US5639454A (en) * 1995-04-06 1997-06-17 Board Of Trustees Operating Michigan State University Recombinant baculovirus with broad host range
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
US5924664A (en) * 1997-03-12 1999-07-20 Ergo View Technologies Corp. Keyboard support mechanism
US6664236B2 (en) * 2002-03-19 2003-12-16 Council Of Scientific And Industrial Research Synergistic composition of bioactive fraction isolated from barleria prionitis linn and a method of treatment for hepatotoxicity, immuno-deficiency and fatigue and a process thereof

Also Published As

Publication number Publication date
EP1503773B1 (de) 2011-03-30
AU2003224361B2 (en) 2008-01-31
JP2005531551A (ja) 2005-10-20
JP4594080B2 (ja) 2010-12-08
WO2003094946A1 (en) 2003-11-20
US7259148B2 (en) 2007-08-21
CN1652808A (zh) 2005-08-10
EP1503773A1 (de) 2005-02-09
AU2003224361A1 (en) 2003-11-11
US20040014684A1 (en) 2004-01-22
EP1503773B9 (de) 2012-01-25
CN100391465C (zh) 2008-06-04
ZA200409048B (en) 2006-12-27

Similar Documents

Publication Publication Date Title
IS2919B (is) Samsetning og andveiruvirkni umskiptra azaindóloxóediksýrupíperazínafleiðna
ATE411332T1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
DE60126814D1 (de) Inhalation von stickoxid
DK1572229T3 (da) Stabilt terapeutisk fibrinogen
ATE261431T1 (de) Kristalline form von (s)-2-ethoxy-3-4-(2-4- methansulfonyloxyphenyl-ethoxy)phenyl)propansäu e
DE60217089D1 (de) Lipidsenkende biphenylcarbonsäureamide
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60307556D1 (de) Verbindungsstruktur von Verbindern
DE60028816D1 (de) Herstellung von unipolaren Komponenten
DE60006799D1 (de) Oralverabreichbare lösung von prucaloprid
DE60336549D1 (de) Hepatoprotektor aktivität von 2'-p-hydroxybenzoylmussaenosidsäure
DE60307022D1 (de) Herstellung von Organohalosilanen
FI20020360A0 (fi) Biologisesti aktiivisen tuotteen uusi käyttö
DE50111597D1 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung
DE50205590D1 (de) Ummantelung von leiterbahnen
DE59803990D1 (de) Verwendung von fettsäurepolyglycolestersulfaten
ITMI20011995A0 (it) Sostanze ad attivita' antinfiammatoria
ITMI20021277A1 (it) Perfluoropolieteri comprendenti unita' ripetitive ottenute dall'ossidazione di perfluorodiossoli
DE50310743D1 (de) Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat
ITBS20020015A1 (it) Centro di attivita' per bambini
DE60326437D1 (de) Therapeutische verwendung von sapogeninen
DE50203046D1 (de) Verwendung von Esterquats
DE50306499D1 (de) Wässrige flüssigformulierungen von pyrazolin-aufhellern
DE60220624D1 (de) Verwendung von Acesulfam als Riechstoff
DE60229222D1 (de) Gewinnung von enzymaktivität aus umhüllten viren